A year ago, Employers Holdings was absorbing a $38.2 million reserve strengthening tied to cumulative trauma claims in California and posting a loss. This quarter offers a cleaner question: can a deliberately smaller workers' compensation insurer keep growing per-share earnings while premiums keep shrinking? Management sounded more confident on its last call than it had in some time. The October 28 report, due after the close, will show whether that confidence rests on durable underwriting gains or on a stretch of favorable math.
Enerpac Tool Group heads into its fiscal fourth-quarter report with two very different stories competing for attention. One is a shrinking near-term outlook, trimmed for a third straight quarter as the Middle East conflict dragged on longer than management expected. The other is the roughly $472 million agreement to buy SFE Group, a deal that would add about $170 million of sales at premium margins and widen the company's addressable market to around $5.5 billion. When Enerpac reports after the close on October 28, the market will be judging whether the core business is stable enough to carry that ambition.
Three months ago, Invitation Homes delivered the most upbeat quarter it had offered in some time: new-lease rents turned positive, renewals re-accelerated, a long-running legislative cloud lifted and management raised its full-year outlook for the first time this cycle. The stock has since fallen 12.5% while the S&P 500 gained 4.1%. That disconnect frames the third-quarter report due after the close on October 28. Either the market is doubting that the rent recovery can hold through the seasonally softer second half, or it is underpricing a story that is still unfolding.
Tyler Technologies heads into its third-quarter report with a more confident story than it has told in some time. Last quarter brought all-time record bookings, SaaS growth above 21%, a closed acquisition and a higher earnings outlook for 2026. The open question is whether that momentum shows up in the numbers this time, or whether the Street has already priced in most of the good news after a strong run in the stock.
UFP Industries heads into its third-quarter report with a split personality. Last quarter the company finally posted its first positive organic volume growth since 2022, powered by booming composite decking and new packaging accounts. It also absorbed a sudden jump of roughly 30% in flatbed freight rates that knocked adjusted EBITDA margin down more than a full point. The question for the October 28 release, due after the close, is simple to state and hard to answer: can top-line momentum outrun a cost shock that management says will linger until pricing catches up, likely not before early 2027?
John B. Sanfilippo & Son enters its fiscal first-quarter report with a problem that a record year could not hide. Revenue hit an all-time high in fiscal 2026 and volume finally turned positive in the fourth quarter. Profit moved the other way, as gross margin slid to 15.7% and quarterly earnings fell to $0.71 a share. The report due after the close on October 28 is the first real test of whether that fourth quarter was a pile-up of one-time hits or the start of a lower-margin stretch. It also arrives as Jasper Sanfilippo takes over as chief executive, with Jeffrey Sanfilippo moving to executive chairman.
Spok heads into its third-quarter report with an unusual problem: the headline profit number will almost certainly look better than the business underneath it. The $8 million sale of narrowband spectrum licenses to CensusUSA closed on July 20, squarely inside this quarter, and management said roughly $7 million of that flows through as a gain with no federal tax owed thanks to deferred tax assets. With about 20 million shares implied by last quarter's $4.1 million in net income and $0.20 per share, that gain alone could add on the order of a third of a dollar to GAAP earnings. Against a year-ago figure of $0.15, the reported growth rate will be eye-catching and largely beside the point.
For a clinical-stage drug developer with no product revenue, an earnings report is less about profits than about the price of progress. That is the lens through which Viking Therapeutics will be judged when it reports third-quarter results after the close on October 28. The stock has fallen sharply since its last update and trades closer to the bottom of its recent range than the top. The key question is whether the company can show that its rising spending is buying meaningful clinical advancement rather than simply draining capital.
Vanda Pharmaceuticals heads into its third-quarter report with a story that has two very different halves. Its antipsychotic Fanapt is posting its best prescription numbers in more than a decade, and the pipeline calendar is crowded with late-2026 catalysts. Yet total revenue went backward last quarter, losses deepened and the stock has slid to the bottom of its recent range. The report due after the close on October 28 needs to show that the growth engine can finally outrun the drags.
Boot Barn heads into its fiscal second-quarter report with an unusual split personality. Management raised its full-year earnings outlook last quarter, yet the stock has dropped nearly 22% since then while the S&P 500 gained 5%. The reason is simple. On the last call, the company acknowledged that July traffic fell across every region and every income level, ending a run of calls in which management routinely highlighted strong quarter-to-date comparable sales. The October 28 report, due after the close, will show whether that soft July was a calendar quirk or the start of a real slowdown.
LENZ Therapeutics heads into its third-quarter report with a simple but unforgiving question hanging over it: did the July spike in VIZZ prescriptions keep going? Last quarter, management pointed to script growth of more than 45% from June to July after launching telehealth prescribing and a national TV campaign. In the same breath, it warned that one month does not make a trend. This report covers the first full quarter of that consumer push. For a stock that has nearly halved since the last update, it is the clearest chance yet to show whether the presbyopia drop can grow without leaning on eye care professionals to drive demand.
Farmland Partners heads into its third-quarter report with a quieter story than it told a year ago, and that is largely by design. Management described its last quarter as deliberately unexciting: a small nudge higher in adjusted funds from operations guidance, offset by a growing reserve against a troubled loan and one of the bleakest assessments of California agriculture the company has offered. The October 28 release, due after the close, will show whether that steady, low-drama posture can hold, or whether the credit and West Coast issues start to dominate.
Landmark Bancorp enters its third-quarter report with a story that improved on almost every front last time except the one that tends to matter most for a community lender: credit. The Manhattan, Kansas bank posted record revenue, its first loan growth in several quarters and steadily rising returns, yet non-performing loans climbed for a second straight quarter. The October 28 release, due after the close, should show which of those two trends has the upper hand.
For most of the past year, Markel told a tidy story: the insurance engine that had sputtered was finally running clean, and the company was using the cash to shrink its share count. Then a collateral shortfall at State National, its fronting business, went from a footnote in the first quarter to the dominant topic of the second-quarter call. When Markel reports third-quarter results after the close on October 28, the question is less whether the underwriting turnaround continues than whether management can draw a firm boundary around a problem that, so far, has only grown.
Acadian Asset Management heads into its third-quarter report with an unusual setup. The business just delivered record assets, record management fees, record margins and record earnings, yet Wall Street expects per-share profit to slip from last quarter even as revenue climbs. That gap between rising sales and softer earnings is the puzzle this report needs to solve, and the answer will say a lot about how durable the systematic manager's profit engine really is.
Ambev heads into its third-quarter report with something it has lacked for a while: genuine momentum. Last quarter, Brazil beer volumes jumped 5%, normalized earnings per share climbed roughly 24%, and first-half operating cash flow surged about 80%. The catch is that part of that lift came from World Cup enthusiasm, which management estimated added half a point to a full point of Brazilian industry growth. The report due before the open on October 29 is the first real chance to see how much of the improvement was structural and how much was a soccer-fueled sugar high.
Three months ago AGCO swapped its bottom-of-the-cycle confidence for a more defensive posture, cutting its full-year outlook after a surprise stumble in Europe and further softness in Latin America. The third-quarter report, due before the opening bell on October 29, is the first real test of whether that reset cleared the decks or simply marked the start of a longer slide. With management having already guided to a deliberately soft quarter, the numbers matter less than what they reveal about the trajectory into 2027.
Allegro MicroSystems heads into its fiscal second-quarter report with an awkward contradiction to resolve. Last quarter the company delivered its sixth straight sequential sales increase, beat the top of its own revenue guide, widened margins and struck its most confident tone in a year. Yet the stock has dropped roughly 20% since that report while the S&P 500 gained about 4.5%. When the numbers arrive before the open on October 29, the question is less whether Allegro can hit its targets and more whether it can show that its growth engine is not running into a ceiling of its own making.
Alnylam heads into its third-quarter report with a credibility question rather than a demand question. Three months ago the company cut its 2026 TTR revenue outlook by roughly $200 million at the midpoint, to $4.2 billion to $4.5 billion, even as US demand growth more than doubled from the first quarter and Amvutra crossed $1 billion in quarterly sales for the first time. Management acknowledged it had set the original guidance too high, mistaking a burst of pent-up second-line demand in 2025 for a durable trend. This report is the first real test of whether the reset bar is conservative enough to clear, or whether the normalization story has further to run.
Ameriprise heads into its third-quarter report with a split personality that the market has chosen to punish. The earnings engine has been accelerating for a year, with adjusted EPS growth climbing from 12% to 22% over four quarters and return on equity reaching 55%. Yet the stock has fallen 8.2% since the last report while the S&P 500 gained 4%, a 12-point gap that suggests investors care less about record profitability than about soft client flows. This quarter is the one where the flow problem should look its worst, because the Comerica departure wraps up in September, while the Huntington offset does not arrive until the fourth quarter.
A.O. Smith heads into its third-quarter report having already told investors this would be the soft spot of the year. Management flagged last quarter that third-quarter earnings would land below both the second and fourth quarters, blaming customer pre-buying that pulled demand forward and a ramp in steel and tariff costs. That makes this release less about whether the quarter is weak and more about whether it is only as weak as promised. Layered on top is a long-awaited conclusion to the company's strategic review of its shrinking China business, which management committed to share by this call.
APi Group heads into its third-quarter report with a peculiar combination: a business that keeps raising its outlook and a stock that keeps going nowhere. Management has lifted its full-year revenue forecast three times in roughly a single quarter, backlog has crossed $5 billion for the first time, and the acquisition machine has shifted into a higher gear. Yet shares are down about 2% since the last report while the S&P 500 gained 4.5%. That gap suggests the market is less worried about whether APi can grow and more worried about what that growth is worth at the margin line.
Ares Management heads into its September-quarter report with a curious disconnect. Last quarter the firm posted the biggest fundraising haul in its history, lifted fee-related earnings by 20% and talked more confidently about its franchise than at any point in the past year. Yet the stock has fallen about 9.5% since then, trailing the S&P 500 by nearly 13 percentage points. The question this report must answer is whether that selloff reflects a real crack in the story or simply anxiety about private credit and wealth-channel flows that the operating numbers do not support.
Altisource Portfolio Solutions has spent the past year proving it can replace shrinking legacy revenue from Onity and Rhythm with business from a broader set of clients. The harder question heading into its third-quarter report on October 29 is whether that growth can start turning into profit. Revenue has been climbing for several quarters while adjusted EBITDA slipped last quarter. Meanwhile, the stock has fallen 17.4% since the last report, trailing the S&P 500 by more than 21 points. The market seems to doubt that the top-line story will carry over to the bottom line.
ASE Technology enters its third-quarter report with a problem most companies would envy: management says demand for its advanced packaging and test capacity is running ahead of its ability to build. That makes this release less about whether customers want more and more about whether ASE can turn a historic spending spree into the margin expansion it has promised. With guidance raised at every call this year, the bar is no longer whether the story is good. It is whether the next step up arrives on schedule.
ATI enters its third-quarter report with an unusual split between what the business says and what the stock says. Three months ago management delivered its strongest quarterly EBITDA since 2007 and raised its 2026 outlook on every major metric. The shares have since fallen about 17% while the S&P 500 was roughly flat. That leaves Thursday's pre-market release with a narrow job. It needs to show the back-half ramp promised in July is actually arriving, not merely postponed again.
Avery Dennison told investors last quarter exactly how its third quarter would look worse, and that is what makes this report interesting. Second-quarter adjusted EPS of $2.89 jumped 19% on 8% organic growth, but management said roughly half of that growth, worth about $0.25 a share, came from customers stocking up ahead of raw-material price increases. It warned that most of that pull-forward should unwind in the third quarter, creating a sequential headwind of about $0.50. The real question is whether the business underneath the pre-buy noise is as healthy as management claims.
Axalta enters its third-quarter report with a business that finally looks to be turning, yet a stock that has not been paid for it. Last quarter delivered record adjusted EBITDA, record adjusted EPS and the first year-over-year growth in refinish after several quarters of channel destocking. Management nonetheless declined to raise its full-year outlook, pointing to building raw-material inflation and geopolitical uncertainty. This report is where those two stories collide: the volume recovery should be gaining traction just as cost pressure is expected to peak.
Bandwidth heads into its third-quarter report with something many communications software companies would envy: a story that improved on every call for a year. Revenue growth stepped up from 12% organic in late 2025 to 20% and then 22% last quarter. Management raised full-year sales and EBITDA guidance and described AI voice as moving from pilots into paying production traffic. The question now is whether the quarter delivers evidence that the newest catalysts are converting into revenue, or whether the guided second-half slowdown in cloud communications turns out to be more than conservatism.
Baxter's last report delivered something the company had not offered in a long while: a raised revenue outlook and a management team that sounded genuinely confident. The market's reaction since then has been far less generous. Shares have fallen 15.7% since that report while the S&P 500 gained 4.5%, leaving the stock about 20 percentage points behind the benchmark. That gap frames the October 29 report, due before the open. The question is whether the second-quarter inflection was real operating progress or a quarter flattered by one-time help.
BBVA heads into its third-quarter report with an odd mismatch. Management spent the last call raising targets almost everywhere it could, yet the stock has slid 6.6% since then while the S&P 500 gained 4.5%. That 11-point gap says the market either doubts the momentum can last or is bracing for the one region that keeps disappointing. The October 29 release, due before the open, is a test of which view is right.
Brunswick has done almost everything a cyclical manufacturer can do in a lukewarm market: four straight quarters of sales growth in every segment, three consecutive increases to its full-year earnings outlook, and margin expansion nearly across the board. The stock has gone the other way. Shares have dropped almost 20% since the last report while the S&P 500 gained about 4.5%, which makes the third-quarter release, due before the open on October 29, less about whether Brunswick can hit a number and more about whether the market believes the earnings improvement can outlast tariff refunds and a hesitant boat buyer.
Most earnings previews revolve around whether a company can clear the bar. For BCB Bancorp, the bar has already been set by management, and it sits deep underground. The New Jersey lender has told the market to expect a third-quarter net loss of roughly $126.2 million to $136.1 million, or about $7.29 to $7.86 per share. When the bank reports before the open on October 29, the real question is not the size of the loss. It is what caused it, how much of the balance sheet it consumed, and whether this quarter marks the end of the damage or merely a chapter in it.
Belden heads into its third-quarter report with an odd mismatch. Last quarter was, by management's own description, the best in company history, with record revenue, record orders and the Ruckus Networks acquisition closing ahead of a newly ambitious growth story. Yet the shares have fallen 5.7% since that report while the S&P 500 gained 4.5%, leaving the stock about 10 points behind the market. The report due before the open on October 29 is the first to include a full quarter of Ruckus, and it will show whether the combined company can turn its enthusiasm into clean, repeatable earnings.
Butterfly Network heads into its third-quarter report having just posted the best quarter in its history, yet the setup calls for revenue to step down sequentially. That is not a contradiction so much as a reminder of how the business now works. The record $32.6 million second quarter was powered by embedded revenue of $10.8 million, much of it tied to milestone-based recognition from MidJourney, and management has framed the more durable embedded baseline at roughly $7 million to $8 million a quarter. This report will show how much of Butterfly's newfound momentum survives once that lumpy contribution normalizes, and whether the core handheld ultrasound franchise can pick up the slack.
Bunge heads into its third-quarter report with an odd disconnect. Management has raised its full-year earnings outlook twice in a row, lifted its Viterra synergy target and talked up a pipeline of renewable-fuel deals. Yet the stock has slid 8.8% since the last report while the S&P 500 gained 3.9%. It now trades near the bottom of its post-earnings range. The October 29 release, due before the open, has to show whether the operating story is still improving or whether the market is right to discount it.
Builders FirstSource heads into its third-quarter report with a credibility problem that has little to do with execution and everything to do with the calendar. Management has trimmed its 2026 outlook three times in a row, and last quarter it explicitly dropped the idea of a second-half recovery after July failed to deliver its usual seasonal peak. The question now is not whether the housing market is weak. It is whether the business has found a floor, or whether a fourth cut is coming.
Three months ago Bristol Myers Squibb did something it had not done all year: it raised its outlook outright, rather than merely reaffirming it or hinting at the upper end. The market has largely shrugged. The stock has slipped about 1.6% since that report while the S&P 500 gained roughly 4.5%, and sentiment toward the name has cooled noticeably. That gap between improving fundamentals and a skeptical tape makes the third-quarter report, due before the open on October 29, a referendum on whether the raise reflected durable momentum or a well-timed quarter.
Anheuser-Busch InBev heads into its third-quarter report with the easiest comparison it is likely to see for some time and the biggest marketing event on its calendar already in the books. A year ago, this quarter was a low point: revenue grew less than 1%, Brazil and Mexico were hit by poor weather, China revenue fell by double digits and underlying EPS barely moved. Since then, management has described a clear turn, with beer volumes back in growth and earnings accelerating. The question now is whether a World Cup summer in North America turns that recovery into something more durable, including the margin expansion that was missing last quarter.
BorgWarner enters its third-quarter report with an odd mismatch. Management left the last call sounding more confident than it had in a year, raising its earnings outlook for the first time after two straight reaffirmations and laying out concrete progress on its data-center power ambitions. The stock has gone the other way, falling 9.4% since that report while the S&P 500 slipped less than 1%. That leaves a company with improving execution, a modest expectations bar and a market that seems unconvinced.
Bankwell Financial Group delivered the kind of quarter last time that changes how a small bank is valued: a 30-basis-point jump in net interest margin to 3.58%, re-accelerating loan growth and the first raise to full-year net interest income guidance in this stretch. The awkward part of the setup heading into the October 29 report is that Wall Street does not seem to fully believe it will repeat. Consensus calls for earnings of $1.41 a share, below the $1.52 posted last quarter. That would still be about 11% better than a year ago, but it implies analysts see some of the second quarter's strength as a high-water mark rather than a new floor.
Blackstone Mortgage Trust heads into its third-quarter report with the market having already delivered a harsh verdict. Shares have fallen 35.1% since the last release, trailing the S&P 500 by nearly 40 percentage points, and at $10.27 the stock trades at barely half of June's $19.31 book value. The question is no longer whether office credit stress has returned. Management confirmed that last quarter. The question is how deep the damage runs and what the Board decides to do with a $0.47 quarterly dividend that earnings no longer comfortably support.
Three months ago Carrier delivered the kind of quarter that usually reprices a stock higher. Management lifted full-year targets for sales, operating profit and earnings, declared residential destocking finished, and pointed to a record backlog fueled by data center demand. The market responded by selling. Shares have fallen almost 17% since that report while the S&P 500 gained 4%, a gap of roughly 21 percentage points. That disconnect is what makes the third-quarter release on October 29 so interesting: the operating story has improved, but investors clearly doubt how much of it will reach the bottom line.
Caterpillar heads into its third-quarter report with an unusual disconnect. Three months ago the company posted its first quarter above $20 billion in sales, raised its full-year revenue outlook for the third straight time and pointed to a record $72 billion backlog. Since then the stock has fallen about 21%, trailing the S&P 500 by more than 22 percentage points. Either the market is looking past the good news toward a peak, or it has punished a company whose fundamentals are still moving in the right direction. The October 29 report, due before the open, should help settle which view is closer to the truth.
CCC Intelligent Solutions heads into its third-quarter report with a stock that has run well ahead of its fundamentals' visible pace. Shares have climbed 39% since the company last reported, beating the S&P 500 by more than 34 percentage points, yet the guidance underpinning that move was only a modest step up. That gap between market enthusiasm and a measured outlook is the central tension when CCC reports before the open on October 29.
Three months ago Cullen/Frost delivered the kind of call bank investors rarely get: higher targets for net interest income, loans and fees, a lower expense forecast, and a rate outlook that flipped from a cut to a hike. The stock's response since then has been a shrug and then some. Shares have slipped 7.7% since that report while the S&P 500 gained 4.5%, leaving the Texas lender roughly 12 points behind the market. That gap frames the third-quarter report due before the open on October 29. Either the market is discounting a story it doesn't yet believe, or it has spotted cracks that management played down.
Climb Global Solutions has spent the past two quarters telling investors that a growth spurt and a profit squeeze can coexist, and that the squeeze is temporary. When the IT distributor reports third-quarter results before the bell on October 29, the market will get its first real look at whether the spending that dented margins last quarter is starting to pay for itself, or whether the company is simply buying growth at a steadily higher price.
CNX Resources heads into its third-quarter report with an unusual split in its numbers: Wall Street expects revenue to shrink sharply from a year ago while earnings per share climb at a healthy clip. That disconnect frames the real question for October 29. Can the company's growing stream of low-carbon credit income, steadily falling drilling costs and aggressive share repurchases keep per-share results rising even as management concedes the near-term natural gas market looks a little soft?
The most revealing number in Cheniere Energy Partners' third-quarter setup is not the headline growth rate. It is the gap between revenue and profit. Wall Street expects the Sabine Pass operator to post slightly higher sales than it did last quarter while earning noticeably less per unit. That combination points to some expected squeeze on margins, and how the partnership explains it will matter more than whether it clears consensus by a few cents.
CRH heads into its third-quarter report with an unusual mismatch. Operating momentum looked solid three months ago, with record second-quarter results and reaffirmed full-year targets. Yet management has since guided below the Street, and the stock has fallen 16.5% while the S&P 500 rose 4.5%. The question now is whether the business is softening or the market is overreacting to a guidance reset and the cost of a large acquisition.